ALB vs PAAS

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in fundamental performance. Despite a strong recent price run-up (+115.4% over 1Y), the company is unprofitable (negative profit and operating margins), has negative earnings growth (YoY), and trades at an extremely high forward P/E of 82.85. While the balance sheet shows a healthy current ratio and manageable debt/equity of 0.37, the lack of Altman Z-Score and Graham Number, combined with deteriorating profitability and insider selling, raises serious concerns about sustainability. The analyst target price of $165.06 implies 13% downside from current levels, reinforcing overvaluation relative to fundamentals.

PAAS exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet (Debt/Equity 0.12). While the current price of $52.29 is well above the defensive Graham Number ($30.91), it remains significantly discounted relative to its growth-based intrinsic value of $75.52 and analyst targets. The company is experiencing explosive YoY earnings growth (258.6%) and maintains superior margins compared to sector averages. Despite a bearish short-term technical trend, the fundamental growth trajectory and low leverage provide a strong bullish case.